| Browser View |
 | | | | How to Find a Bargain in the Growing Cannabis Industry | | Matthew Carr, Emerging Trends Strategist, The Oxford Club | | | [LEAKED] This Multi-Billion Dollar 'Flaw' is Why Your Internet Costs So Much One tech insider is revealing the billion-dollar 'flaw' that could KILL "Big Cable." In an epic rant he posted online, this insider also uncovers a "Holy Grail" alternative internet.
One that could offer the entire country high-speed connections for as little as $7 per month!
But what REALLY has people excited?
Is how RICH this new tech could make early investors.
Click here now for the full story. | | | In Thursday's "State of the Industry," I pointed out that March is the beginning of "pot smoking season."
This is when we see sales spike, especially in Colorado. And we enter the busy season for the industry that stretches all the way to September.
But so far, March hasn't been kind to anyone... especially cannabis companies.
The North American Marijuana Index has fallen more than 6% already this month... On top of that, we had a number of headline moves last week - including that pervasive trend of mergers and acquisitions.
It also demonstrated how incestuous the industry is.
Aurora Cannabis (NYSE: ACB) bought Cronos Group's (Nasdaq: CRON) 19% stake in Whistler Medical Marijuana Corp. for $131.4 million.
Recently, Choom Holdings (OTC: CHOOF) agreed to acquire Clarity MD Cannabis Holdings. This gives Choom 30 retail locations, with three licensed by the Alberta Gaming, Liquor & Cannabis Commission. Aurora has invested $27 million in Choom since June 2018.
Then we had Altria's (NYSE: MO) 45% stake in Cronos close on Friday, with new executives named.
Finally, we saw the nascent nature of the industry on display as well. We covered shares of Village Farms International (Nasdaq: VFF) getting uplisted, and it was recently one of our Top 5 Pot Stocks to Watch.
Shares just resumed trading on the Nasdaq after having been halted for a few days.
Making the Grade
With the recent pullback in pot stocks, my team and I decided to revisit an indicator we've looked at before: the relative strength index (RSI).
If you recall, this momentum indicator measures the magnitude of recent price changes.
It's pretty straightforward.
An RSI reading above 70 is considered overbought (or overvalued).
A reading below 30 is oversold (or undervalued).
But we also want to look at a company's RSI compared with its industry's rating.
About a month ago, we found that the average RSI for pot stocks was about 55.9. Today, it's a bit lower at around 51.5.
And you can see the cannabis companies not only above that average but also above that 70 level... Terranueva Corp. (CSE: TEQ) tops the list of most overbought stocks. Shares have been on fire, surging more than 150% year to date.
Heritage Cannabis (CSE: CANN) is another stock that's blown up this year - jumping nearly 250% so far.
And we see two other companies that appear below in this week's "High Five."
Now let's turn to the bargains in the cannabis space... Compared with other high-flying pot stocks, companies like NewBridge Global (OTC: NBGV), Green Growth Brands (OTC: GGBXF) and Wayland Group (CSE: WAYL) have posted disappointing performances.
One stock that stands out on the list is Acreage Holdings (OTC: ACRGF), the largest U.S. cannabis vertical. It also happens to own the No. 1 spot in this week's top pot stocks to watch... | | | This FCC Regulation Is a Joke
It's in place to ensure that every cellphone sold is "safe."
Each must emit only so much radiation. But the test is garbage.
And once you've seen the amount of radiation blasting your brain... you'll never use your phone the same way again.
Click here for the shocking video. | | | The High Five
1) Acreage Holdings (OTC: ACRGF) is the largest multistate operator in the U.S. It has licenses in 19 states with a projected total addressable market of $14 billion by 2022. In the third quarter, revenue surged 160% to $5.5 million. And after the market closes tomorrow, the cannabis vertical will report fourth quarter earnings.
2) HEXO Corp. (NYSE: HEXO) will also report earnings this week. This Thursday before the opening bell we'll get second quarter fiscal year 2019 results.
In HEXO's first quarter results, adult-use revenue surged 371%. Sales volume increased to 952,223 grams, with 81% of that being dried flower. As happened to a lot of Canadian producers on that first report after legalization, HEXO shares dipped because of the smaller profit margins on dried flower. The company also saw 90% of its sales come from Canada.
3) GrowGeneration Corp. (OTC: GRWG) acquired Reno Hydroponics last month. But that was one of four acquisitions the hydroponic and organic gardening chain has made in 2019, including three in February.
But GrowGeneration is bullish on Reno because of the Nevada cannabis market. There are 50 legal cannabis establishments within 100 miles of Reno.
The company's two other acquisitions last month were in California and Colorado. And in the third quarter, GrowGeneration's revenue jumped 109% to $8.4 million. The acquisition of Chlorophyll Inc. in Colorado is expected to add $8 million in revenue to GrowGeneration.
4) Cannex Capital Holdings (OTC: CNXXF) shares surged on Friday. 4Front is merging with the company. The new entity will trade under Cannex's ticker on the Canadian Stock Exchange. This deal was originally announced back in November.
Back in January, Cannex reported second quarter revenue surged 223% to $3.05 million. And since then, the company has announced a couple of acquisitions, including Pure Ratios, which gives Cannex exposure to the ultra-hot CBD market.
5) Halo Labs (OTC: AGEEF) kicked off March by reporting record revenue in February. The extraction company reported $2.6 million in sales last month. And California represented 60% of that total. CEO Kiran Sidhu said, "We are laser focused on the massive opportunity we believe we have in the state of California."
Last week was a tough one for the markets and for pot stocks. The Horizons Marijuana Life Sciences ETF (OTC: HMLSF) slipped more than 5% as the broader indexes struggled to keep their feet.
Year to date, our "High Five" - the five pot stocks we're watching right now - have been heading in different directions... Acreage, HEXO and GrowGeneration have lagged the Horizons Marijuana ETF in 2019. But as we showed in "Making the Grade," Acreage is in oversold territory.
Meanwhile, Cannex and Halo have doubled the performance of the ETF, soaring more than 100% already this year. These two also appeared in our list of 10 overbought cannabis stocks based on RSI.
But that doesn't mean there isn't anything left in the tank. Investors might want to wait for a pullback to make a splash in those two.
The broader markets got tripped up last week over U.S.-China trade deal hopes. And even though that has nothing to do with the marijuana industry, speculative investments like cannabis will be hit by increased volatility.
Remember that these dips can provide better entry points... especially if technical indicators like RSI tell us the stocks we're watching are oversold.
If you have a pot stock in mind that you'd like me to discuss here, leave the ticker symbol in the comments section.
Good investing,
Matthew | | | | | | | | — More From Energy & Resources Digest — | | | | | | | | | | | JUST RELEASED: FREE RETIREMENT BOOK (Limited Quantities)
 This 155-page, hardbound book crammed with 101 proven secrets for generating a lifetime of income...
Is yours FREE through this special offer.
But you need to act now to claim it.
Only 500 FREE copies are available today.
>>Find Out How to Get Yours Here<< | | | |
| | |
| | |
The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. 
No comments:
Post a Comment